Literature DB >> 10711699

Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales' disease.

H N Madhavan1, K L Therese, P Gunisha, U Jayanthi, J Biswas.   

Abstract

PURPOSE: Tuberculous etiology has been suggested in Eales' disease. Because epiretinal membrane (ERM) is formed on the inner surface of the retina in Eales' disease, it could be the most appropriate intraocular specimen for investigation. Therefore, a nested polymerase chain reaction (nPCR), which detects MPB64 gene of Mycobacterium tuberculosis on the archival specimens of ERM of well-documented Eales' and non-Eales' patients, was applied and the results compared.
METHODS: nPCR technique was standardized, and the sensitivity and specificity of the primers were determined. nPCR technique was applied to tissue sections obtained from formalin-fixed and paraffin-embedded tissues of ERM from 23 patients with Eales' disease and 27 noninfective and non-Eales' disease patients as controls.
RESULTS: nPCR technique was specific for M. tuberculosis genome and sensitive enough to detect 0.25 fg (corresponding to the presence of a single bacillus). Eleven (47.8%) ERM of 23 Eales' disease and 3 (11.1%) of 27 controls were positive for M. tuberculosis genome. The difference between the two groups was statistically significant (P = 0.001), indicating association of this bacterium with Eales' disease.
CONCLUSIONS: The demonstration of the presence of M. tuberculosis DNA by nPCR technique in significant number of ERM of Eales' disease compared with the controls further emphasizes the probable role of this bacterium in the pathogenesis of this enigmatic clinical condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711699

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  31 in total

1.  Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).

Authors:  A M Abu El-Asrar; S A Al-Kharashi
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

Review 2.  Current approach in the diagnosis and management of posterior uveitis.

Authors:  S Sudharshan; Sudha K Ganesh; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

3.  New diagnostic approach for ocular tuberculosis by ELISA using the cord factor as antigen.

Authors:  J Sakai ; S Matsuzawa; M Usui; I Yano
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

4.  Profiling of human leukocyte antigens in Eales disease and tuberculosis.

Authors:  Shan-jun Cai; Gang Su; Hong Li; Bing Xie; Jun-min Luo
Journal:  Int Ophthalmol       Date:  2013-02-06       Impact factor: 2.031

5.  Further evidence of the association of latent Mycobacterium tuberculosis in Eales' disease.

Authors:  Prasad Gupta; Jyotirmay Biswas
Journal:  Int Ophthalmol       Date:  2020-11-16       Impact factor: 2.031

6.  Tuberculous uveitis.

Authors:  Ahmed M; Abu El-Asrar; Marwan Abouammoh; Hani S Al-Mezaine
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

7.  Tuberculous uveitis, a resurgent and underdiagnosed disease.

Authors:  Luca Cimino; Carl P Herbort; Raffaella Aldigeri; Carlo Salvarani; Luigi Boiardi
Journal:  Int Ophthalmol       Date:  2007-05-08       Impact factor: 2.031

8.  Characterization of mutations in the rpoB gene conferring rifampicin resistance in Mycobacterium tuberculosis complex isolated from lymph nodes of slaughtered cattle from South Africa.

Authors:  Nolwazi L Bhembe; Ezekiel Green
Journal:  Braz J Microbiol       Date:  2020-08-05       Impact factor: 2.476

9.  PCR-like cascade reactions in the context of an allosteric enzyme mimic.

Authors:  Hyo Jae Yoon; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2008-08-06       Impact factor: 15.419

10.  Polymerase chain reaction in intraocular inflammation.

Authors:  Krishnendu Nandi; Prabhat Ranjan; Lily Therese; Jyotirmay Biswas
Journal:  Open Ophthalmol J       Date:  2008-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.